Kaposi's Sarcoma Case Raises Questions for OX40/OX40L in AD
A Frontiers article asks whether Kaposi's sarcoma signals the end of OX40/OX40L targeting in atopic dermatitis, raising tumor-safety questions for the costimulation pipeline.
Topic
Ox40 Ox40l
Topic